BIOFLOW-V: A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions

Back

ESC Premium Access

BIOFLOW-V: A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions

Session: Late-Breaking Science in PCI 1

Topic: PCI / stents: devices and technique

Speaker: Doctor D. Kandzari (Atlanta, US)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor David Kandzari

Atlanta (United States of America)

2 presentations

0 follower

6 more presentations in this session

Comparison of titanium-nitride-oxide-coated versus everolimus-eluting stents in acute coronary syndrome

Speaker: Doctor P. Tonino (Eindhoven, NL)

A Multicenter, Randomized-Controlled, Blinded Trial of Drug-Eluting vs. Bare Metal Stents in De Novo Saphenous Vein Graft Lesions

Speaker: Mr E. Brilakis (Minneapolis, US)

Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized controlled trial

Speaker: Professor M. Hong (Seoul, KR)

Access

Slides

Video

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention and Survival in Patients with Type 1 Diabetes Mellitus

Speaker: Doctor M. Holzmann (Stockholm, SE)

Access

Slides

Video

Five-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Speaker: Doctor M. Natsuaki (Saga, JP)

Access

Slides

Video

Access the full session

Late-Breaking Science in PCI 1

Speakers: Doctor D. Kandzari, Doctor P. Tonino, Mr E. Brilakis, Professor M. Hong, Doctor M. Holzmann...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

BIOFLOW-V: A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions

About the speaker

Doctor David Kandzari

6 more presentations in this session

Comparison of titanium-nitride-oxide-coated versus everolimus-eluting stents in acute coronary syndrome

A Multicenter, Randomized-Controlled, Blinded Trial of Drug-Eluting vs. Bare Metal Stents in De Novo Saphenous Vein Graft Lesions

Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized controlled trial

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention and Survival in Patients with Type 1 Diabetes Mellitus

Five-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Access the full session

Late-Breaking Science in PCI 1

About the event

ESC Congress 2017

ESC 365 is supported by